Kamada Ltd
KMDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567529
In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Kamada Ltd changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 25 | +2 |
| Shares | 5.92M | 5.75M | −168.5K (−2.8%) |
| Value | $31.0M | $30.8M | −$233.8K (−0.8%) |
New holders (6)
Institutions that held Kamada Ltd at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Aristides Capital LLC | 40,000 | $213.6K | 0.14% |
| Y.D. More Investments Ltd | 14,002 | $74.8K | 0.02% |
| BlackRock Inc. | 10,633 | $56.8K | 0.00% |
| UBS Group AG | 2,338 | $12.5K | 0.00% |
| Barclays PLC | 926 | $4.95K | 0.00% |
| Qube Research & Technologies Ltd | 1 | $5 | 0.00% |
Sold out (4)
Institutions that held Kamada Ltd at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Calton & Associates, Inc. | 19,630 | $103.5K |
| JPMorgan Chase & Co | 15,826 | $83.5K |
| Bank of Montreal | 49,391 | $70.2K |
| Bank of America Corp | 5,181 | $27.3K |